RNF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.678760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.412000E-01
Normal-vs-Stage2
1.422570E-01
Normal-vs-Stage3
5.463200E-01
Normal-vs-Stage4
6.404400E-02
Stage1-vs-Stage2
2.754400E-01
Stage1-vs-Stage3
7.551000E-01
Stage1-vs-Stage4
5.238300E-02
Stage2-vs-Stage3
6.688600E-01
Stage2-vs-Stage4
1.203790E-01
Stage3-vs-Stage4
3.227600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.895620E-01
Normal-vs-AfricanAmerican
3.465000E-01
Normal-vs-Asian
6.638400E-02
Caucasian-vs-AfricanAmerican
7.277200E-01
Caucasian-vs-Asian
3.375200E-01
AfricanAmerican-vs-Asian
3.333200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.607620E-01
Normal-vs-Female
1.901440E-01
Male-vs-Female
8.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.340000E-01
Normal-vs-Age(41-60Yrs)
5.076300E-02
Normal-vs-Age(61-80Yrs)
2.812400E-01
Normal-vs-Age(81-100Yrs)
7.806100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.962840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.138400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.853000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.256300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.821400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.677600E-01
Normal-vs-Daily Drinker
2.544800E-01
Normal-vs-Weekly Drinker
1.422550E-01
Normal-vs-Occasional Drinker
4.608500E-02
Normal-vs-Social Drinker
3.616600E-01
Non Drinker-vs-Daily Drinker
5.740000E-01
Non Drinker-vs-Weekly Drinker
7.986800E-01
Non Drinker-vs-Occasional Drinker
4.965700E-02
Non Drinker-vs-Social Drinker
7.292000E-01
Daily Drinker-vs-Weekly Drinker
7.793800E-01
Daily Drinker-vs-Occasional Drinker
1.752030E-01
Daily Drinker-vs-Social Drinker
3.967800E-01
Weekly Drinker-vs-Occasional Drinker
7.960300E-02
Weekly Drinker-vs-Social Drinker
5.014600E-01
Occasional Drinker-vs-Social Drinker
2.437500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.760020E-01
Normal-vs-Grade 2
3.762300E-03
Normal-vs-Grade 3
1.658200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.940800E-03
Grade 1-vs-Grade 3
1.773900E-02
Grade 1-vs-Grade 4
1.760020E-01
Grade 2-vs-Grade 3
5.076000E-01
Grade 2-vs-Grade 4
3.762300E-03
Grade 3-vs-Grade 4
1.658200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.683400E-01
Normal-vs-NonDiabetic
1.143830E-01
Diabetic-vs-NonDiabetic
1.162630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.335200E-03
Normal-vs-NoPancreatitis
1.970240E-01
Pancreatitis-vs-NoPancreatitis
1.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.827900E-02
Normal-vs-N1
1.621000E-01
N0-vs-N1
2.881800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.025500E-02
Normal-vs-TP53-NonMutant
7.466000E-01
TP53-Mutant-vs-TP53-NonMutant
7.24799997797732E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
